Quris-AI, MBZUAI to set up Bio-AI centre in Abu-Dhabi

Quris-AI, MBZUAI to set up Bio-AI centre in Abu-Dhabi

Quris-AI and Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) have signed an agreement to develop a world-class Bio-AI centre in Abu Dhabi.

The state-of-the-art facility will support the development of personalised medications, tailored specifically to the diverse populations of the MENA region.

The agreement was signed during the Abu Dhabi Sustainability Week (ADSW).

The collaboration will establish a centre of excellence in Bio-AI in Abu Dhabi, which will accelerate the development of safer, and highly personalised medications. MBZUAI provides expertise in the development of predictive AI models, while incentivising sought-after AI graduates to stay in the UAE as they begin their careers, said a statement.

Quris-AI, a pioneer in AI drug safety, developed the world’s first Bio-AI clinical prediction platform, which makes drug development faster and more efficient, and promises to save hundreds of millions of dollars in research and development costs. With this collaboration Quris, which has operations in Boston and Tel-Aviv, is now establishing its subsidiary, Quris-UAE in Abu Dhabi.

Targeted drug development

Currently, around 90% of clinical trials for new medications end in failure, but Quris’ proprietary ‘patient-on-a-chip’ technology promises to reduce failure by predicting which drugs are most likely to work in humans. The Quris system rapidly performs test interactions using